Search research articles
Contact Us
Filters
Showing results (111-120 of 155) with videos related to
Page
of 16
Sort By:
Journal of the National Cancer Institute
|
August 20, 2025
Circulating tumor DNA driving anti-EGFR rechallenge therapy in metastatic colorectal cancer: the RASINTRO prospective multicenter study
Aziz Zaanan, Elisabeth Sophie Bergen, Ludovic Evesque, et al.
International Journal of Cancer
|
November 13, 2020
Panel gene profiling of small bowel adenocarcinoma: Results from the NADEGE prospective cohort
Thomas Aparicio, Magali Svrcek, Julie Henriques, et al.
Annals of Intensive Care
|
March 9, 2022
Result of one-year, prospective follow-up of intensive care unit survivors after SARS-CoV-2 pneumonia
Guillaume Eberst, Fréderic Claudé, Lucie Laurent, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 15, 2022
Neoadjuvant Nivolumab Plus Ipilimumab and Adjuvant Nivolumab in Localized Deficient Mismatch Repair/Microsatellite Instability-High Gastric or Esophagogastric Junction Adenocarcinoma: The GERCOR NEONIPIGA Phase II Study
Thierry André, David Tougeron, Guillaume Piessen, et al.
Ebiomedicine
|
May 17, 2025
Deciphering human endogenous retrovirus expression in colorectal cancers: exploratory analysis regarding prognostic value in liver metastases
Julien Viot, Romain Loyon, Nawfel Adib, et al.
International Journal of Cancer
|
January 9, 2020
Small bowel adenocarcinoma: Results from a nationwide prospective ARCAD-NADEGE cohort study of 347 patients
Thomas Aparicio, Julie Henriques, Sylvain Manfredi, et al.
JHEP Reports : Innovation in Hepatology
|
February 3, 2025
First-line chemotherapy with selective internal radiation therapy for intrahepatic cholangiocarcinoma: The French ACABi GERCOR PRONOBIL cohort
Nicolas Adamus, Julien Edeline, Julie Henriques, et al.
Frontiers in Oncology
|
August 5, 2022
A Phase II Study Evaluating the Interest to Combine UCPVax, a Telomerase CD4 T<sub>H</sub>1-Inducer Cancer Vaccine, and Atezolizumab for the Treatment of HPV Positive Cancers: VolATIL Study
Magali Rebucci-Peixoto, Angélique Vienot, Olivier Adotevi, et al.
Bulletin Du Cancer
|
February 15, 2020
[Localized MSI/dMMR gastric cancer patients, perioperative immunotherapy instead of chemotherapy: The GERCOR NEONIPIGA phase II study is opened to recruitment]
Romain Cohen, Thomas Pudlarz, Marie-Line Garcia-Larnicol, et al.
The New England Journal of Medicine
|
September 27, 2013
Complement-binding anti-HLA antibodies and kidney-allograft survival
Alexandre Loupy, Carmen Lefaucheur, Dewi Vernerey, et al.
Page
of 16
Search research articles
Search
Showing results (111-120 of 155) with videos related to
Sort By:
Page
of 16
Journal of the National Cancer Institute
|
August 20, 2025
Circulating tumor DNA driving anti-EGFR rechallenge therapy in metastatic colorectal cancer: the RASINTRO prospective multicenter study
Aziz Zaanan, Elisabeth Sophie Bergen, Ludovic Evesque, et al.
International Journal of Cancer
|
November 13, 2020
Panel gene profiling of small bowel adenocarcinoma: Results from the NADEGE prospective cohort
Thomas Aparicio, Magali Svrcek, Julie Henriques, et al.
Annals of Intensive Care
|
March 9, 2022
Result of one-year, prospective follow-up of intensive care unit survivors after SARS-CoV-2 pneumonia
Guillaume Eberst, Fréderic Claudé, Lucie Laurent, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 15, 2022
Neoadjuvant Nivolumab Plus Ipilimumab and Adjuvant Nivolumab in Localized Deficient Mismatch Repair/Microsatellite Instability-High Gastric or Esophagogastric Junction Adenocarcinoma: The GERCOR NEONIPIGA Phase II Study
Thierry André, David Tougeron, Guillaume Piessen, et al.
Ebiomedicine
|
May 17, 2025
Deciphering human endogenous retrovirus expression in colorectal cancers: exploratory analysis regarding prognostic value in liver metastases
Julien Viot, Romain Loyon, Nawfel Adib, et al.
International Journal of Cancer
|
January 9, 2020
Small bowel adenocarcinoma: Results from a nationwide prospective ARCAD-NADEGE cohort study of 347 patients
Thomas Aparicio, Julie Henriques, Sylvain Manfredi, et al.
JHEP Reports : Innovation in Hepatology
|
February 3, 2025
First-line chemotherapy with selective internal radiation therapy for intrahepatic cholangiocarcinoma: The French ACABi GERCOR PRONOBIL cohort
Nicolas Adamus, Julien Edeline, Julie Henriques, et al.
Frontiers in Oncology
|
August 5, 2022
A Phase II Study Evaluating the Interest to Combine UCPVax, a Telomerase CD4 T<sub>H</sub>1-Inducer Cancer Vaccine, and Atezolizumab for the Treatment of HPV Positive Cancers: VolATIL Study
Magali Rebucci-Peixoto, Angélique Vienot, Olivier Adotevi, et al.
Bulletin Du Cancer
|
February 15, 2020
[Localized MSI/dMMR gastric cancer patients, perioperative immunotherapy instead of chemotherapy: The GERCOR NEONIPIGA phase II study is opened to recruitment]
Romain Cohen, Thomas Pudlarz, Marie-Line Garcia-Larnicol, et al.
The New England Journal of Medicine
|
September 27, 2013
Complement-binding anti-HLA antibodies and kidney-allograft survival
Alexandre Loupy, Carmen Lefaucheur, Dewi Vernerey, et al.
Page
of 16